Genome editing of both humans and other organisms is increasingly a subject of debate both in the media and amongst policy makers. International frenzy was sparked last year when the world’s first editing was done in human embryo in China, not to mention the most recent approval to edit genes in human embryos in the UK.
About the Speaker
Sarion Bowers is the policy lead for the Wellcome Trust Sanger Institute, where she provides advice and guidance to researchers, legislators, policy makers on bioethics, research regulation and science policy. She was originally a research scientist with expertise in chromatin and gene regulation before changing careers and specialising in science and technology policy relating to genomics. Sarion has a particular interest in the ethical, legal and societal issues that arise from the use of genomics in the clinic and the development of new genomic technologies, including genome editing.
About the Sanger Institute
For your information, the Sanger Institute is one of the world’s foremost centres for genomic science, often known as the 'home of the genome' as a third of the Human Genome Project was completed there. It has led the way in decoding the genome and understanding its significance to human health over the past 15 years.